JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39 | -9.3% | 21,498 | -43.5% | 0.00% | – |
| Q4 2022 | $43 | -99.9% | 38,071 | +33.4% | 0.00% | – |
| Q3 2022 | $66,000 | -91.9% | 28,543 | -89.4% | 0.00% | -100.0% |
| Q2 2022 | $819,000 | -73.8% | 270,286 | -41.2% | 0.00% | -50.0% |
| Q1 2022 | $3,122,000 | -74.0% | 459,909 | -68.0% | 0.00% | 0.0% |
| Q4 2021 | $12,002,000 | +3927.5% | 1,437,238 | +3480.0% | 0.00% | – |
| Q3 2021 | $298,000 | +2.8% | 40,146 | -5.6% | 0.00% | – |
| Q2 2021 | $290,000 | +21.3% | 42,538 | +82.2% | 0.00% | – |
| Q1 2021 | $239,000 | +512.8% | 23,342 | +319.1% | 0.00% | – |
| Q4 2020 | $39,000 | -42.6% | 5,569 | -33.7% | 0.00% | – |
| Q3 2020 | $68,000 | +3.0% | 8,402 | -11.9% | 0.00% | – |
| Q2 2020 | $66,000 | +153.8% | 9,536 | +70.6% | 0.00% | – |
| Q1 2020 | $26,000 | -81.9% | 5,591 | -66.1% | 0.00% | – |
| Q4 2019 | $144,000 | +289.2% | 16,515 | +51.0% | 0.00% | – |
| Q3 2019 | $37,000 | -44.8% | 10,937 | -19.0% | 0.00% | – |
| Q2 2019 | $67,000 | -64.6% | 13,496 | -55.6% | 0.00% | – |
| Q1 2019 | $189,000 | +44.3% | 30,370 | -22.0% | 0.00% | – |
| Q4 2018 | $131,000 | -68.4% | 38,934 | -39.2% | 0.00% | – |
| Q3 2018 | $415,000 | +7.2% | 64,034 | +26.8% | 0.00% | – |
| Q2 2018 | $387,000 | -88.9% | 50,488 | -67.5% | 0.00% | -100.0% |
| Q1 2018 | $3,478,000 | +5509.7% | 155,583 | +3078.4% | 0.00% | – |
| Q4 2017 | $62,000 | -16.2% | 4,895 | +4.2% | 0.00% | – |
| Q3 2017 | $74,000 | +105.6% | 4,698 | +80.3% | 0.00% | – |
| Q2 2017 | $36,000 | +16.1% | 2,605 | +86.1% | 0.00% | – |
| Q1 2017 | $31,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |